CorDx

Medtronic exists to solve the world's most challenging health problems through bold innovation and advanced technology. For over 75 years, the company has pioneered groundbreaking health tech that transforms lives, treating more than 70 conditions across the human body - from heart failure to Parkinson's disease. As a global leader in healthcare technology, Medtronic leverages data, AI, and cutting-edge therapies to address complex healthcare challenges that affect millions of people worldwide. With 95,000 employees across 150 countries, the company's mission-driven approach combines medical expertise with technological innovation to restore health, extend life, and alleviate pain for patients everywhere. From its humble beginnings in a Minneapolis garage to becoming the world's largest medical technology company, Medtronic continues to push boundaries and redefine what's possible in healthcare, making a meaningful impact on global health outcomes every day through innovations that put more life into patients' years.

Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With over 75 years of heritage, Alcon stands as the largest eye care device company in the world, operating in 60 countries and serving patients in more than 140 countries globally. The company's complementary businesses in Surgical and Vision Care deliver the broadest portfolio of products designed to enhance sight and improve lives. Founded in 1945 by pharmacists Robert Alexander and William Conner in Fort Worth, Texas, Alcon has built a legacy of industry firsts that continues to define the standard of care in ophthalmology. The company invests substantially in research and development, committing over $876 million annually to pioneer life-changing innovations that address unmet patient needs. From revolutionary intraocular lenses like AcrySof to advanced water gradient contact lenses such as DAILIES TOTAL1, Alcon's product pipeline encompasses more than 70 products under development. The company's integrated approach spans surgical equipment, vision correction devices, pharmaceutical treatments, and diagnostic technologies, enabling comprehensive eye care solutions across the entire patient journey. Alcon's mission-driven culture centers on the belief that when people see brilliantly, they live brilliantly.

Monte Rosa Therapeutics is a clinical-stage biotechnology company focused on developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases. The company’s work centers on degrading proteins - 'Degrading Proteins, Making Medicines' - and advancing precision approaches that target undruggable or inadequately drugged proteins with unprecedented specificity. On its website, the team is described as combining expertise in molecular glue degrader (MGD) chemistry, artificial intelligence (AI), structural biology, and proteomics. Monte Rosa’s QuEEN
9 (Quantitative and Engineered Elimination of Neosubstrates) discovery engine is described as using AI-guided chemistry alongside diverse chemical libraries, structural biology, and proteomics to identify degradable protein targets and rationally design MGDs. The company positions this platform as enabling access to a wide-ranging, differentiated target space across multiple therapeutic areas, and references advancing multiple MGD programs through its pipeline. The company is headquartered in Boston, Massachusetts, and also lists a Basel, Switzerland location on its site.

AbbVie is a global biopharmaceutical company with a mission to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives. When you trust AbbVie with your data, you help advance treatments to some of the world's most difficult health problems, ensuring that patients receive the care they need. The company employs approximately 57,000 people worldwide and operates in 170+ countries, working tirelessly to transform the standard of care across multiple therapeutic areas including immunology, oncology, neuroscience, and more. Founded in 2013 as a separate company from Abbott Laboratories, AbbVie builds on a proud legacy while forging ahead with cutting-edge research and development. The company is committed to being fully transparent and compliant with policies, ensuring fairness and transparency in how personal data is handled. From clinical research to personalized patient support programs, AbbVie puts patients first, developing innovative medicines that have real impact on people's lives around the world.

The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules. Our team is dedicated to bringing innovative medicines from bench to bedside, with operations spanning multiple locations across North America, Europe, and Asia. We conduct research, clinical development, and commercial operations out of these global locations. Idorsia's corporate responsibility efforts encompass employee development and diversity, governance and ethics, as well as the organization's economic, environmental, and social performance.

ARX Robotics builds Europe's leading autonomous mobile robotics and a comprehensive digitalization platform for modernizing legacy fleets. The company develops deployment-ready systems and software that strengthen Europe's technological resilience across every mission, securing European sovereignty and protecting freedom and democracy through advanced defense technology. ARX specializes in dual-use autonomous unmanned ground systems and sensors for the European defense sector, assisting NATO armies and civilian first responders in tackling their most challenging problems. The company's product portfolio includes Gereon RCS, Mithra OS for fleet modernization, and Hector - a scalable land capability platform. With headquarters in Munich and offices in Berlin, London, and Kyiv, ARX Robotics drives innovation through swift development, quick decision-making, and efficient execution.